Xcellerex is revolutionizing the way biotherapeutics & vaccines
are developed, manufactured & commercialized.

Recent News:

Xcellerex announces milestone sale of FlexFactoryTM biomanufacturing line and XDR single-use bioreactors to Crucell, N.V. more

Listen to Xcellerex Founder/CTO Parrish Galliher's webcast describing FlexFactoryTM technology more

BioProcess International magazine features technical article on CHO scale-up in XDR single-use bioreactors more

Learn how Xcellerex GMP contract manufacturing can save you 50% or more vs. other CMOs... Is Today's Biomanufacturing Model Broken?